First- and midtrimester Down syndrome screening and detection

Clinics in Perinatology

Volumn 31, Issue 4, 2004, Pages 677-694

  Bahado Singh, Ray O ^a   Choi, Sang Joon ^b   Cheng, Chih Chien ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Chosun University   (South Korea)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BIOMETRY; CHROMOSOME DISORDER; CONSENSUS DEVELOPMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FACIAL BONE; FEMUR; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; HUMERUS; HYPOPLASIA; MEDICAL ASSESSMENT; MEDICAL PRACTICE; MIDFACE HYPOPLASIA; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; STATISTICAL SIGNIFICANCE; TRISOMY 18; URINALYSIS;

BIOLOGICAL MARKERS; BIOMETRY; DOWN SYNDROME; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 7044224895     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2004.06.002     Document Type: Review

References (91)

1. L.Y.F. Hsu Prenatal diagnosis of chromosomal abnormalities through amniocentesis A. Milunsky Genetic disorders and the fetus. Diagnosis, prevention, and treatment 1998 John Hopkins University Press Baltimore (MD) 179 183
2. J. Nielsen, M. Wohlert, J. Fauborg-Anderson, K.B. Hansen, L. Hvidman, and B. Krag-Olsen Incidence of chromosome abnormalities in newborn children: comparison between incidence in 1969-1974 and 1980-1982 in the same area Hum Genet 61 1982 98 101
3. M.A. Ferguson-Smith, and J.R.W. Yates Maternal age-specific rate for chromosome abnormalities and factors influencing them: report of a collaborative European study of 52,965 amniocentesis Prenat Diag 4 1984 5 44
4. R.J.M. Snijders, and K.H. Nicolaides Fetal abnormalities R.J.M. Snijders K.H. Nicolaides Ultrasound markers for fetal chromosome defects 1996 Parthenon Publishing Group New York 1 37
5. B.D. Sohl, A.L. Scioscia, N.E. Budorick, and T.R. Moore Utility of minor ultrasonographic markers in the prediction of abnormal fetal karyotype at prenatal diagnostic centers Am J Obstet Gynecol 181 1999 898 903
6. D.A. Nyberg, V.L. Souter, A. El-Bastawissi, S. Young, F. Luthardt, and D.A. Luthy Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy J Ultrasound Med 20 2001 1053 1063
7. S. Rotmensch, M. Liberati, M. Bronshtein, M. Schoenfeld-Dimarui, and J. Shaller Prenatal sonographic findings in 187 fetuses with Down syndrome Prenat Diagn 17 1997 1001 1009
8. R.O. Bahado-Singh, I. Mendilcioglu, and M. Rowther Early genetic sonogram for Down syndrome detection Am J Obstet Gynecol 187 2002 1235 1238
9. P. Vergani, A. Locatelli, and M.G. Piccoli Best second trimester sonographic markers for the detection of Trisomy 21 J Ultrasound 18 1999 469 473
10. J.C. Hobbins, D.C. Lezotte, and W.H. Persutte An 8-center study to evaluate the utility of mid-term genetic sonograms among high-risk pregnancies J Ultrasound Med 22 2003 33 38
11. E. Jauniaux, L.V. Maldergem, C.D. Munter, and G. Moscoso Non-immune hydrops fetalis associated with genetic abnormalities Obstet Gynecol 75 1990 568 572
12. K.H. Nicolaides, R.J.M. Snijders, C.M. Gosden, C. Berry, and S. Campbell Ultrasonographically detectable markers of fetal chromosomal abnormalities Lancet 340 1992 704 707
13. D.A. Nyberg, D. Kramer, R.G. Resta, and R. Kapur Prenatal sonographic finding of Trisomy 18: review of 47 cases J Ultrasound Med 2 1993 103 113
14. A.L. Bundy, D.H. Saltzman, and B. Pober Antenatal sonographic findings in Trisomy 18 J Ultrasound Med 5 1986 361 364
15. R.O. Bahado-Singh, S.J. Choi, U. Oz, I. Mendelcioglu, M. Rowther, and W. Persutte Early mid-trimester individualized estimation of Trisomy 18 risk by ultrasound Obstet Gynecol 101 2003 463 468
16. C. Lockwood, B. Benacerraf, and A. Krinsky A sonographic screening method for Down syndrome Am J Obstet Gyn 157 1987 803 808
17. B.R. Benacerraf, F.D. Frigoletto Jr, and D.W. Cramer Down syndrome: sonographic signs for diagnosis in the second trimester fetus Radiology 163 1987 811 813
18. R. Perella, A.J. Duerinck, E.G. Grant, F. Tessler, K. Tabsch, and B.F. Crandall Second trimester sonographic diagnosis of Down syndrome: role of femur-length shortening and nuchal fold thickening Am J Radiology 151 1988 981 985
19. B.R. Benacerraf, D. Neuberg, and F.D. Frigoletto Jr Humeral shortening in second trimester fetuses with Down syndrome Obstet Gynecol 77 1991 223 227
20. S. Rotmensch, J.S. Luo, M. Liberati, K. Belanger, M.J. Mahoney, and J.C. Hobbins Fetal humerus length to detect Down Syndrome Am J Obstet Gynecol 166 1992 1330 1334
21. A.M. Vintzileos, and J.F.X. Egan Adjusting the risk for Trisomy 21 on the basis of second trimester ultrasonography Am J Obstet Gynecol 172 1995 837 844
22. B.R. Benacerraf, V.A. Banss, and L.A. Laboda A sonographic sign for the detection of the second trimester of the fetus with Down syndrome Am J Gynecol 151 1985 1078 1079
23. B.R. Benacerraf, R. Gelman, and F.D. Frigoletto Jr Sonographic identification of second trimester fetuses with Down's syndrome N Engl J Med 159 1987 181 189
24. A. Toi, G.F. Simpson, and R.A. Filly Ultrasonically evident fetal nuchal skin thickening: is it specific for Down syndrome? Am J Obstet Gynecol 156 1987 150 153
25. A.E. Donnenfield, D.E. Carlson, G.E. Palomaki, R.J. Librizzi, S. Weiner, and L.D. Platt Prospective multicenter study of second trimester nuchal skin fold thickness in unaffected and Down syndrome pregnancies Obstet Gynecol 84 1994 844 847
26. A.M. Vintzileos, W.A. Campbell, and E.R. Guzman Second trimester ultrasound markers for detection of Trisomy 21: which markers are best? Obstet Gynecol 89 1997 941 944
27. R.O. Bahado-Singh, U.A. Oz, and E. Kovanci Gestational age-standardized nuchal thickness values for estimating mid-trimester Down's syndrome risk J Matern Fetal Med 8 1999 37 43
28. H. Grandjean, M.F. Sarramon AFDPHE Study Group Sonographic measurement of nuchal skinfold thickness for detection of Down syndrome in the second trimester fetus: a multicenter prospective study Obstet Gynecol 85 1995 103 106
29. R. Bahado-Singh, O. Deren, and U. Oz An alternative for women initially declining genetic amniocentesis: individualized Down syndrome odds on basis of maternal age and multiple ultrasonographic markers Am J Obstet Gynecol 179 1998 514 519
30. D.A. Nyberg, T. Dubinsky, and R.G. Resta Echogenic fetal bowel during the second trimester: clinical importance Radiology 188 1993 527 531
31. R. Bahado-Singh, R. Morotti, and J.A. Copel Hyperechoic fetal bowel: the perinatal consequence Prenat Diagn 14 1994 981 987
32. D.J. Roberts, and D. Genest Cardiac histologic pathology characteristic of Trisomy 13 and 21 Hum Pathol 23 1992 1130 1140
33. C. Tennstedt, R. Chaoui, M. Vogel, B. Goldner, and M. Dietel Pathologic correlation of sonographic echogenic foci in the fetal heart Prenat Diagn 20 2000 287 292
34. N. Anderson, and R. Jyotz Relationship of isolated fetal intracardiac echogenic focus to Trisomy 21 in the mid-trimester sonogram in women younger than 35 years Ultrasound Obstet Gynecol 21 2003 354 358
35. T.A. Shipp, and B.R. Benacerraf Second trimester ultrasound screening for chromosomal abnormalities Prenat Diagn 22 2002 296 307
36. I.C. Huggon, A.C. Cook, J.M. Simpson, N.C. Smeeton, and G.K. Sharland Isolated echogenic foci in the fetal heart as a marker of chromosome abnormality Ultrasound Obstet Gynecol 17 2001 11 16
37. A. Sotiriadis, G. Makrydimas, and P.A. Ionnidis Diagnostic performance of intracardiac echogenic foci for Down syndrome: a meta-analysis Obstet Gynecol 101 2003 1009 1016
38. T.D. Shipp, B. Bromley, E. Lieberman, and B.R. Benacerraf The frequency of the detection of fetal echogenic intracardiac foci with respect to maternal race Ultrasound Obstet Gynecol 15 2000
39. S. Cicero, P. Curcio, A. Papagerghiou, J. Sonek, and K. Nicolaides Absent nasal bone in fetuses with Trisomy 21 at 11-14 weeks of gestation: an observational study Lancet 358 2001 1665 1667
40. B. Bromley, E. Lieberman, T.D. Shipp, and B.R. Benacerraf Fetal nasal bone length J Ultrasound Med 21 2002 1387 1394
41. S. Cicero, J.D. Sonek, D.S. McKenna, C.S. Croom, L. Johnson, and K.H. Nicolaides Nasal bone hypoplasia in Trisomy 21 at 15-22 weeks gestation Ultrasound Obstet Gynecol 21 2003 15 18
42. A. Vintzileos, C. Walters, and L. Yeo Absent nasal bone in Trisomy 21 in a high-risk population Obstet Gynecol 101 2003 905 908
43. W. Lee, G.R. DeVore, C.H. Comstock, K.D. Kalache, B. McNie, and T. Chaiworapongsa Nasal bone evaluation in fetuses with Down syndrome during the second and third trimesters of pregnancy J Ultrasound Med 22 2003 55 60
44. V. Bunduki, R. Ruano, J. Miguelez, C.T. Yoshizaki, S. Kahhale, and M. Zugaib Fetal nasal bone length: reference range and clinical application in ultrasound screening for Trisomy 21 Ultrasound Obstet Gynecol 21 2003 156 160
45. Sonek Ultrasound Obstet Gynecol 27 2003 152 155
46. M. Chen, C.P. Lee, K.Y. Leung, P.W. Hui, and M.H.Y. Tang Pilot study on the mid-second trimester examination of fetal nasal bone in the Chinese population Prenat Diagn 24 2004 87 91
47. I.R. Merkatz, H.M. Nitowsky, J.N. Macri, and W.E. Johnson An association between low maternal serum alpha-feto protein and fetal chromosomal abnormalities Am J Obstet Gynecol 148 1984 886 894
48. A. Baumgarten AFP screening and Down syndrome Lancet 751 1985
49. N.J. Wald, A. Kennard, A. Hackenshaw, and A. McGuire Antenatal screening for Down's syndrome Health Technol Assess 2 1998 9 32
50. J.A. Canick, G.J. Knight, G.E. Palomaki, J.E. Haddow, H.S. Cuckle, and N.J. Wald Low second trimester maternal serum unconjugated oestriol in pregnancies with Down syndrome Br J Obstet Gynecol 95 1988 330 333
51. P.A. Benn Advances in prenatal screening for Down syndrome. I. General principles and second trimester testing Clin Chim Acta 323 2002 1 16
52. J.M. Van Lith, J.J. Pratt, J.R. Beekhuis, and A. Mantingh Second-trimester maternal serum immuno-reactive inhibin as a marker for fetal Down's syndrome Prenat Diagn 12 1992 801 806
53. N.J. Wald, J.W. Densen, L. George, S. Muttukrishna, and P.G. Knight Prenatal screening for Down's syndrome using inhibin-A as a serum marker Prenat Diagn 16 1996 143 152
54. S. Stone, R. Henely, T. Reynolds, and R. John A comparison of total and free β-hCG assays in Down syndrome screening Prenat Diagn 13 1993 535 537
55. H.S. Cuckle, R.K. Iles, and T. Chard Urinary β-core human chorionic gonadotropin: a new approach to Down's syndrome screening Prenat Diagn 14 1994 953 958
56. L.A. Cole, K. Rinne, S.M. Mahajan, U.A. Oz, S. Shahabi, M.J. Mahoney, and R.O. Bahado-Singh Urinary screening tests for fetal Down syndrome. I. Fresh β-core fragment Prenat Diagn 1999 340 350
57. J.A. Canick, L.H. Kellner, L.A. Cole, and H.S. Cuckle Urinary analyte screening: a noninvasive detection method for Down syndrome? Mol Med Today 19 1999 146 148
58. L.A. Cole, D. Cermik, and R.O. Bahado-Singh Oligosaccharide variants of hCG-related molecules: potential screening markers for Down syndrome Prenat Diagn 17 1997 1188 1190
59. L.A. Cole, S. Shahabi, U.A. Oz, R.O. Bahado-Singh, and M.J. Mahoney Hyperglycosylated human chorinic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening Clin Chem 45 1999 2109 2119
60. R.O. Bahado-Singh, U. Oz, K. Rinne, D. Hunter, L.A. Cole, and M.J. Mahoney Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second trimester detection of Down syndrome Am J Obstet Gynecol 181 1999 929 933
61. F.A. Chervenak, G. Isaacson, K.J. Blakemore, R.N. Brea, J.C. Hobbins, and R.L. Berowitz Fetal cystic hygroma: cause and natural history N Engl J Med 309 1983 822 825
62. M.T. Cullen, S. Gabrielli, J.J. Green, N. Rizzo, M.F. Mahoney, and C. Salafia Prenat Diagn 10 1990 643 651
63. R.M. Van Zalen-Sprock, J.M.G. Van Vugt, and H.P. Van Geijn First-trimester diagnosis of cystic hygroma-course and outcome Am J Obstet Gynecol 167 1992 94 98
64. J. Szabo, and J. Gellen Nuchal fluid accumulation in Trisomy 21 detected by vaginosonography in first trimester Lancet 336 1990 1133
65. K.H. Nicolaides, G. Azar, D. Byrne, C. Mansur, and K. Marks BMJ 304 1992 867 869
66. S. Bohlandt, C.S. von Kaisenberg, K. Wewetzer, B. Christ, K.H. Nicolaides, and B. Brand-Saberi Hyaluronan in the nuchal skin of chromosomally abnormal fetuses Hum Reprod 15 2000 1155 1158
67. D. Chitayat, D.K. Kalousek, and J.S. Bamforth Lymphatic abnormality in fetuses with posterior cervical cystic hygroma Am J Med Genet 33 1989 352 356
68. J. Hyett, G. Moscoso, and K. Nicolaides Increased nuchal translucency in Trisomy 21 fetuses: relationship to narrowing of the aurotic isthmus Hum Reprod 10 1995 3049 3051
69. R.J.M. Snijders, P. Noble, N. Sebire, and K.H. Nicolaides UK multicenter project on assessment of risk of Trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group Lancet 352 1998 343 346
70. B.W.J. Mol, E. Pajkrt, J.M.M. Van Lith, and C.M. Bilardo Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation [letter] Br J Obstet Gynecol 103 1996 1051 1052
71. A.K. Hackenshaw, N.J. Wald, and J.E. Haddow Down syndrome screening with nuchal translucency [letter] Lancet 348 1996 1740
72. B.W.J. Mol, J.G. Lijmer, J. Van der Muelen, E. Pajkrt, C.M. Bilardo, and P.M.M. Bossuyt Effect study design on the association between nuchal translucency measurement and Down syndrome Obstet Gynecol 94 1999 864 869
73. P. Panburana, S. Ajjimakorn, and P. Tungkajiwangoon First trimester Down syndrome screening by nuchal translucency in a Thai population Int J Gynecol Obstet 75 2001 311 312
74. K. Schuchter, E. Hafner, G. Stangl, E. Ogris, and K. Phillipp Sequential screening for Trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in a low risk population Ultrasound Obstet Gynecol 18 2001 23 25
75. M.L. Brizot, M.H. Carvalho, A.W. Liao, N.S. Reis, E. Armbruster-Moraes, and M. Zugaib First trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population Ultrasound Obstet Gynecol 18 2001 652 655
76. J.A. Crossley, D.A. Aitken, A.D. Cameron, E. McBride, and J.M. Connor Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicenter study Br J Obstet Gynecol 109 2002 667 676
77. N.J. Wald, C. Rodeck, A.K. Hackshaw, L. Walters, L. Chitty, and A. Mackinson First and second trimester antenatal screening for Down's syndrome: the results of the serum, urine and ultrasound screening study (SURUSS) Health Technol Assess 11 2003 1 84
78. K. Spencer, J.N. Macri, D.A. Aitken, and J.M. Connor Free beta hCG as first trimester marker for fetal Trisomy Lancet 339 1992 1480
79. B. Brambati, A. Lanzini, and L. Tului Ultrasound and biochemical assessment during the first trimester of pregnancy M. Chapman G. Grudzinska T. Charo The embryo: normal and abnormal development and growth 1991 Springer-Verlag London 181 194
80. H.S. Cuckle, and J.M.M. Van Lith Appropriate biochemical parameters in first trimester screening for Down's syndrome Prenat Diagn 19 1999 505 512
81. J.E. Haddow, G.E. Palomaki, G.J. Knight, J. Williams, W.A. Miller, and A. Johnson Screening of maternal serum for fetal Down's syndrome in the first trimester N Engl J Med 338 1998 955 961
82. F. Orlandi, G. Damiani, T.W. Hallahan, D.A. Kranz, and J.N. Macri First trimester screening for fetal aneuploidy: biochemistry and nuchal translucency Ultrasound Obstet Gynecol 10 1997 381 386
83. R. Biagiotti, L. Brizzi, E. Periti, A. d'Agata, E. Vanzi, and E. Cariati First trimester screening for Down's syndrome using maternal serum PAPP-A and free β-hCG in combination with fetal nuchal translucency thickness Br J Obstet Gynecol 105 1998 917 920
84. K. Schuchter, E. Hafner, G. Staugl, M. Metzenbauer, D. Hofinger, and Philipp The first trimester "combined test" for the detection of Down syndrome pregnancies in 4939 unselected pregnancies Prenat Diagn 22 2002 211 215
85. D.A. Krantz, T.W. Hallahan, F. Orlandi, P. Buchanan, J.W. Larsen, and J.N. Macri First trimester Down syndrome screening using dried blood biochemistry and nuchal translucency Obstet Gynecol 96 2000 207 213
86. R. Bindra, V. Heath, A. Liao, K. Spencer, and K.H. Nicolaides One stop clinic for assessment of risk for Trisomy 21 at 11-14 weeks: a prospective study of 15030 pregnancies Ultrasound Obstet Gynecol 20 2002 219 225
87. P.L. Noble, H.D. Abraha, R.J.M. Snijders, R. Sherwood, and K.H. Nicolaides Screening for fetal Trisomy 21 in the first trimester of pregnancy: maternal serum free β-hCG and fetal nuchal translucency thickness Ultrasound Obstet Gynecol 1995 390 395
88. F. Muller, M. Benattar, A. Francois, N. Roussel, S. Dreux, and H. Cuckle First trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers Prenat Diagn 23 2003 833 836
89. S.T. Chasen, G. Sharma, R.B. Kalish, and F.A. Chervenak First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population Ultrasound Obstet Gynecol 22 2003 149 151
90. R.W. Wapner, E. Thom, J.L. Simpson, E. Pergament, R. Silver, and K. Filkins First-trimester screening for Trisomies 21 and 18 N Engl J Med 349 2003 1405 1413
91. F.D. Malone, N.J. Wald, J.A. Canick, R.H. Ball, D.A. Nyberg, and C.H. Comstock First and second trimester evaluation of risk (FASTER) trial: principal results of NICHD Multicenter Down Syndrome Screening Study [abstract] Am J Obstet Gynecol 189 2003 556